Advertisement
Screener

REPLIGEN CORP (RGEN) Interest Expense

2.8 / 5 stars · 68/120 Roast Me

REPLIGEN CORP Interest Expense

REPLIGEN CORP (RGEN) reported Interest Expense of $4.98 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-07-30.

Discontinued › Expense Statement

us-gaap:InterestExpense · last filed 2024-07-30

  • REPLIGEN CORP interest expense for the quarter ending 2024-06-30 was $4.98M, a 1717.88% increase year-over-year.
  • REPLIGEN CORP interest expense for the quarter ending 2024-03-31 was $4.89M, a 1711.48% increase year-over-year.
  • REPLIGEN CORP interest expense for the quarter ending 2023-12-31 was $1.14M, a 321.48% increase year-over-year.
  • REPLIGEN CORP interest expense for the quarter ending 2023-09-30 was $269.00K, a 18.24% decline year-over-year.
  • REPLIGEN CORP interest expense for fiscal 2023 was $1.95M, a 67.90% increase from fiscal 2022.
  • REPLIGEN CORP interest expense for fiscal 2022 was $1.16M, a 89.70% decline from fiscal 2021.
  • REPLIGEN CORP interest expense for fiscal 2021 was $11.28M, a 4.74% increase from fiscal 2020.
  • REPLIGEN CORP interest expense for fiscal 2020 was $10.77M, a 15.88% increase from fiscal 2019.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 6 month as first filedInterest Expense 9 monthInterest Expense 9 month as first filedInterest Expense 12 monthInterest Expense 12 month as first filed
2024-06-30$4.98M
10-Q · filed 2024-07-30
$9.87M
10-Q · filed 2024-07-30
$11.01M
derived: sum of 3 quarters · filed 2024-07-30
$11.28M
derived: sum of 4 quarters · filed 2024-07-30
2024-03-31$4.89M
10-Q · filed 2024-05-01
$6.03M
derived: sum of 2 quarters · filed 2024-05-01
$6.30M
derived: sum of 3 quarters · filed 2024-05-01
$6.57M
derived: sum of 4 quarters · filed 2024-07-30
2023-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$1.41M
derived: sum of 2 quarters · filed 2024-02-22
$1.68M
derived: sum of 3 quarters · filed 2024-07-30
$1.95M
10-K · filed 2024-02-22
2023-09-30$269.00K
10-Q · filed 2023-10-31
$543.00K
derived: sum of 2 quarters · filed 2024-07-30
$813.00K
10-Q · filed 2023-10-31
$1.08M
derived: sum of 4 quarters · filed 2024-07-30
2023-06-30$274.00K
10-Q · filed 2024-07-30
$544.00K
10-Q · filed 2024-07-30
$814.00K
derived: sum of 3 quarters · filed 2024-07-30
$1.14M
derived: sum of 4 quarters · filed 2024-07-30
2023-03-31$270.00K
10-Q · filed 2024-05-01
$540.00K
derived: sum of 2 quarters · filed 2024-05-01
$869.00K
derived: sum of 3 quarters · filed 2024-05-01
$1.14M
derived: sum of 4 quarters · filed 2024-05-01
2022-12-31$270.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$599.00K
derived: sum of 2 quarters · filed 2024-02-22
$870.00K
derived: sum of 3 quarters · filed 2024-02-22
$1.16M
10-K · filed 2024-02-22
2022-09-30$329.00K
10-Q · filed 2023-10-31
$600.00K
derived: sum of 2 quarters · filed 2023-10-31
$892.00K
10-Q · filed 2023-10-31
$3.77M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$271.00K
10-Q · filed 2023-08-02
$563.00K
10-Q · filed 2023-08-02
$3.44M
derived: sum of 3 quarters · filed 2024-02-22
$6.30M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$292.00K
10-Q · filed 2023-05-02
$3.17M
derived: sum of 2 quarters · filed 2024-02-22
$6.03M
derived: sum of 3 quarters · filed 2024-02-22
$8.82M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$2.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$5.74M
derived: sum of 2 quarters · filed 2024-02-22
$8.52M
derived: sum of 3 quarters · filed 2024-02-22
$11.28M
10-K · filed 2024-02-22
$12.71M
10-K · filed 2022-02-17
2021-09-30$2.86M
10-Q · filed 2022-11-01
$3.22M
10-Q · filed 2021-10-28
$5.65M
derived: sum of 2 quarters · filed 2022-11-01
$8.40M
10-Q · filed 2022-11-01
$9.47M
10-Q · filed 2021-10-28
$10.14M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$2.79M
10-Q · filed 2022-08-02
$3.14M
10-Q · filed 2021-07-27
$5.54M
10-Q · filed 2022-08-02
$6.25M
10-Q · filed 2021-07-27
$7.28M
derived: sum of 3 quarters · filed 2023-02-22
$10.33M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$2.75M
10-Q · filed 2022-04-27
$3.11M
10-Q · filed 2021-05-04
$4.49M
derived: sum of 2 quarters · filed 2023-02-22
$7.54M
derived: sum of 3 quarters · filed 2023-02-22
$10.55M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$1.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$4.79M
derived: sum of 2 quarters · filed 2023-02-22
$7.79M
derived: sum of 3 quarters · filed 2023-02-22
$10.77M
10-K · filed 2023-02-22
$12.13M
10-K · filed 2021-02-24
2020-09-30$3.05M
10-Q · filed 2021-10-28
$6.06M
derived: sum of 2 quarters · filed 2021-10-28
$9.03M
10-Q · filed 2021-10-28
$12.00M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$3.00M
10-Q · filed 2021-07-27
$5.98M
10-Q · filed 2021-07-27
$8.95M
derived: sum of 3 quarters · filed 2022-02-17
$11.80M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$2.98M
10-Q · filed 2021-05-04
$5.94M
derived: sum of 2 quarters · filed 2022-02-17
$8.80M
derived: sum of 3 quarters · filed 2022-02-17
$10.54M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$2.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$5.82M
derived: sum of 2 quarters · filed 2022-02-17
$7.57M
derived: sum of 3 quarters · filed 2022-02-17
$9.29M
10-K · filed 2022-02-17
2019-09-30$2.86M
10-Q · filed 2020-11-05
$4.60M
derived: sum of 2 quarters · filed 2020-11-05
$6.33M
10-Q · filed 2020-11-05
$8.03M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$1.74M
10-Q · filed 2020-07-30
$3.47M
10-Q · filed 2020-07-30
$5.17M
derived: sum of 3 quarters · filed 2021-02-24
$6.86M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$1.73M
10-Q · filed 2020-05-06
$3.43M
derived: sum of 2 quarters · filed 2021-02-24
$5.11M
derived: sum of 3 quarters · filed 2021-02-24
$6.78M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$3.39M
derived: sum of 2 quarters · filed 2021-02-24
$5.06M
derived: sum of 3 quarters · filed 2021-02-24
$6.71M
10-K · filed 2021-02-24
2018-09-30$1.69M
10-Q · filed 2019-10-31
$3.36M
derived: sum of 2 quarters · filed 2019-10-31
$5.01M
10-Q · filed 2019-10-31
$6.64M
derived: sum of 4 quarters · filed 2019-10-31
2018-06-30$1.67M
10-Q · filed 2019-08-01
$3.32M
10-Q · filed 2019-08-01
$4.96M
derived: sum of 3 quarters · filed 2019-08-01
$6.58M
derived: sum of 4 quarters · filed 2019-08-01
2018-03-31$1.65M
10-Q · filed 2019-05-09
$3.29M
derived: sum of 2 quarters · filed 2019-05-09
$4.91M
derived: sum of 3 quarters · filed 2019-05-09
$6.51M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$1.64M
10-K · filed 2018-02-22
$3.25M
derived: sum of 2 quarters · filed 2018-11-01
$4.86M
derived: sum of 3 quarters · filed 2018-11-01
$6.44M
10-K · filed 2020-02-26
2017-09-30$1.62M
10-Q · filed 2018-11-01
$3.22M
derived: sum of 2 quarters · filed 2018-11-01
$4.80M
10-Q · filed 2018-11-01
$6.37M
derived: sum of 4 quarters · filed 2018-11-01
2017-06-30$1.60M
10-Q · filed 2018-08-02
$3.19M
10-Q · filed 2018-08-02
$4.76M
derived: sum of 3 quarters · filed 2018-08-02
$6.31M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$1.58M
10-Q · filed 2018-05-08
$3.15M
derived: sum of 2 quarters · filed 2018-05-08
$4.71M
derived: sum of 3 quarters · filed 2018-05-08
$5.35M
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31$1.57M
10-K · filed 2018-02-22
$3.13M
derived: sum of 2 quarters · filed 2018-02-22
$3.76M
derived: sum of 3 quarters · filed 2018-02-22
$3.77M
10-K · filed 2019-03-01
2016-09-30$1.55M
10-K · filed 2018-02-22
$2.19M
derived: sum of 2 quarters · filed 2018-02-22
$2.20M
10-Q · filed 2017-11-09
$2.21M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$638.00K
10-Q · filed 2017-08-03
$643.00K
10-Q · filed 2017-08-03
$651.00K
derived: sum of 3 quarters · filed 2018-02-22
$659.00K
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$5.00K
10-K · filed 2018-02-22
$13.00K
derived: sum of 2 quarters · filed 2018-02-22
$21.00K
derived: sum of 3 quarters · filed 2018-02-22
$29.00K
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$8.00K
10-K · filed 2017-02-23
$16.00K
derived: sum of 2 quarters · filed 2017-02-23
$24.00K
derived: sum of 3 quarters · filed 2017-02-23
$32.00K
10-K · filed 2018-02-22
2015-09-30$8.00K
10-K · filed 2017-02-23
$16.00K
derived: sum of 2 quarters · filed 2017-02-23
$24.00K
10-Q · filed 2016-11-03
$37.00K
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$8.00K
10-K · filed 2017-02-23
$7.79K
10-Q · filed 2015-08-06
$17.00K
10-Q · filed 2016-08-04
$16.83K
10-Q · filed 2015-08-06
$29.00K
derived: sum of 3 quarters · filed 2017-02-23
$40.00K
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$9.00K
10-K · filed 2017-02-23
$9.04K
10-Q · filed 2015-05-08
$21.00K
derived: sum of 2 quarters · filed 2017-02-23
$32.00K
derived: sum of 3 quarters · filed 2017-02-23
$45.00K
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$12.00K
10-K · filed 2016-02-25
$23.00K
derived: sum of 2 quarters · filed 2016-02-25
$36.00K
derived: sum of 3 quarters · filed 2016-02-25
$50.00K
10-K · filed 2017-02-23
$49.96K
10-K · filed 2015-03-17
2014-09-30$11.00K
10-K · filed 2016-02-25
$11.49K
10-Q · filed 2014-11-07
$24.00K
derived: sum of 2 quarters · filed 2016-02-25
$38.00K
10-Q · filed 2015-11-05
$38.35K
10-Q · filed 2014-11-07
$50.36K
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$13.00K
10-K · filed 2016-02-25
$12.78K
10-Q · filed 2014-08-11
$26.86K
10-Q · filed 2015-08-06
$39.36K
derived: sum of 3 quarters · filed 2016-02-25
$51.07K
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$14.00K
10-K · filed 2016-02-25
$14.09K
10-Q · filed 2014-05-09
$26.36K
derived: sum of 2 quarters · filed 2016-02-25
$38.07K
derived: sum of 3 quarters · filed 2016-02-25
$50.47K
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$12.36K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$24.07K
derived: sum of 2 quarters · filed 2016-02-25
$36.47K
derived: sum of 3 quarters · filed 2016-02-25
$50.00K
10-K · filed 2016-02-25
$49.85K
10-K · filed 2014-03-14
2013-09-30$11.70K
10-Q · filed 2014-11-07
$24.11K
derived: sum of 2 quarters · filed 2014-11-07
$37.64K
10-Q · filed 2014-11-07
$51.64K
derived: sum of 4 quarters · filed 2014-11-07
2013-06-30$12.40K
10-Q · filed 2014-08-11
$25.93K
10-Q · filed 2014-08-11
$39.93K
derived: sum of 3 quarters · filed 2014-08-11
$32.93K
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$13.53K
10-Q · filed 2014-05-09
$27.53K
derived: sum of 2 quarters · filed 2014-05-09
$20.53K
derived: sum of 3 quarters · filed 2014-05-09
$47.89K
derived: sum of 4 quarters · filed 2014-05-09
2012-12-31$14.00K
10-K · filed 2013-03-15
$7.00K
derived: sum of 2 quarters · filed 2013-03-15
$34.36K
derived: sum of 3 quarters · filed 2013-08-07
$56.71K
10-K · filed 2015-03-17
2012-09-30-$7.00K
10-K · filed 2013-03-15
-$7.21K
10-Q · filed 2012-11-08
$20.36K
derived: sum of 2 quarters · filed 2013-08-07
$42.54K
10-Q · filed 2012-11-08
$70.74K
derived: sum of 4 quarters · filed 2013-08-07
2012-06-30$27.36K
10-Q · filed 2013-08-07
$49.74K
10-Q · filed 2013-08-07
$77.74K
derived: sum of 3 quarters · filed 2013-08-07
$77.74K
derived: sum of 4 quarters · filed 2013-08-07
2012-03-31$22.38K
10-Q · filed 2013-05-07
$50.38K
derived: sum of 2 quarters · filed 2013-05-07
$50.38K
derived: sum of 3 quarters · filed 2013-05-07
$50.87K
derived: sum of 4 quarters · filed 2013-05-07
2011-12-31$28.00K
10-K · filed 2013-03-15
$28.00K
derived: sum of 2 quarters · filed 2013-03-15
$27.77K
10-K · filed 2014-03-14
$41.48K
derived: sum of 4 quarters · filed 2013-03-15
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$484.00
derived: sum of 2 quarters · filed 2012-11-08
$13.48K
10-Q · filed 2012-11-08
2011-06-30$484.00
derived: 10-Q 6 month − 10-K 3 month · filed 2012-08-09
$13.48K
10-Q · filed 2012-08-09
2011-03-31$13.00K
10-K · filed 2013-03-15
$13.48K
10-Q · filed 2012-05-10
$26.17K
10-K · filed 2013-03-15
2010-12-31$12.68K
10-K · filed 2014-03-14
2010-03-31$1.97K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78